Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Syncona (SYNC)

Price 97.50p on 20-01-2025 at 17:30:00
Change -1.50p -1.52%
Buy 98.20p
Sell 97.60p
Buy / Sell SYNC Shares
Last Trade: Sell 29,972.00 at 97.50p
Day's Volume: 567,090
Last Close: 97.50p
Open: 99.00p
ISIN: GG00B8P59C08
Day's Range 97.50p - 99.00p
52wk Range: 90.00p - 131.60p
Market Capitalisation: £608m
VWAP: 98.32025p
Shares in Issue: 624m

Recent Trades History Syncona (SYNC)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 29,972 97.50p Uncrossing Trade
16:35:17 - 20-Jan-25
Sell* 109 97.60p Automatic Execution
16:29:54 - 20-Jan-25
Sell* 184 97.60p Automatic Execution
16:29:05 - 20-Jan-25
Sell* 184 97.60p Automatic Execution
16:28:05 - 20-Jan-25
Sell* 67 97.60p Automatic Execution
16:26:29 - 20-Jan-25
Sell* 1,939 97.60p Automatic Execution
16:24:01 - 20-Jan-25
Sell* 256 97.60p Automatic Execution
16:22:21 - 20-Jan-25
Sell* 1,938 97.60p Automatic Execution
16:22:21 - 20-Jan-25
Sell* 1,939 97.60p Automatic Execution
16:20:18 - 20-Jan-25
Sell* 1,762 97.60p Automatic Execution
16:19:43 - 20-Jan-25

Share Price History for Syncona

Time period:
to
Date Open High Low Close Volume

Share News for Syncona

LONDON MARKET MIDDAY: Stocks red ahead of US trade balance read

27th Dec 2024 12:11

(Alliance News) - Stock prices in London were mostly lower at midday on Friday as market participants continue digesting US jobless data and unrest in Mozambique puts miners on edge. Read More

Syncona investee sells assets to AstraZeneca for USD12 million

27th Dec 2024 09:11

(Alliance News) - Syncona Ltd on Friday said one of its investments Achilles Therapeutics PLC has sold its technology assets to AstraZeneca PLC for USD12 million. Read More

LONDON BRIEFING: Stocks seen down as holiday sales stabilise

27th Dec 2024 07:59

(Alliance News) - The FTSE 100 index in London was called slightly lower on Friday, as investors digest holiday-season sales results in the US and UK. Read More

Syncona hails positive trial data for new Beacon Therapeutics drug

6th Dec 2024 14:55

(Alliance News) - Syncona Ltd on Friday reported promising trial results for the drug laru-zova, the lead asset of Syncona subsidiary Beacon Therapeutics Holdings Ltd. Read More

Syncona net assets values down; announces new portfolio firm Slingshot

14th Nov 2024 12:28

(Alliance News) - Syncona Ltd on Thursday said it launched a new portfolio company as it reported a fall in net asset value, citing a weaker US dollar. Read More

FTSE 100 Latest
Value8,520.54
Change15.32

Login to your account

Forgot Password?

Not Registered